The Latest

Sonora Quest Laboratories Partners with uMETHOD Health

Sonora Quest Laboratories, Arizona's leading provider of diagnostic testing and information services, has announced a partnership with uMETHOD Health, a health technology company offering the first platform for Alzheimer's disease based on advanced artificial intelligence technology. Through the partnership, healthcare providers will have access to the RestoreU METHOD via Sonora Quest for their patients experiencing memory loss. The platform includes lab tests and individualized care plans to assess and minimize…READ MORE

Dr. Walker featured on Healthline

Dr. John Q. Walker, uMETHOD Health's CTO, was recently quoted in an article for Healthline about a new study to help predict dementia 10 years in advance. The article covers a new Danish study that used genetics to help predict people's risk of developing dementia 10 years before they would typically be diagnosed. The study found that as we age, our risk of developing dementia or Alzheimer's disease keeps increasing. The research team…READ MORE

John Q. Walker to Speak at the Precision Medicine World Conference

Dr. John Q. Walker, uMETHOD Health co-founder and Chief Technology Officer, will be a featured speaker at the Precision Medicine World Conference held at Duke University on September 24-25, 2018. Dr. Walker's presentation, "Solving Alzheimer's," will cover the dozens of factors that contribute to Alzheimer's cognitive decline, including genetics, blood chemistry, medications, medical history, diet, and lifestyle. It will also address multi-domain interventions for this complex disease. PMWC 2018 Duke is…READ MORE

uMETHOD Health featured on Caring.com

Caring.com is the leading online destination for those seeking information and support as they care for aging parents, spouses, and other loved ones. The site recently added a post on the link between menopause and Alzheimer’s disease. When it comes to Alzheimer’s, women are disproportionality affected, both in getting the disease as well as being the main caregiver for loved ones. The Careing.com articles states that “scientists aren't sure why…READ MORE

uMETHOD Health recognized in local news

The News and Observer, a daily newspaper serving the Triangle area in Raleigh, NC, has a feature article on uMETHOD’s unique AI approach to Alzheimer’s disease. The paper is the second largest in the state and has been awarded multiple Pulitzer Prizes. Ray Gronberg wrote the article titled “Can AI give hope to Alzheimer’s patients? This Raleigh start-up says yes.” To read the full article, click here.…READ MORE

Two Steps Forward, One Back In Alzheimer’s and Brain Awareness Month

Alzheimer's and Brain Awareness Month may have come to a close, but the important work of finding treatments continues. Despite drug development setbacks, several major announcements made during June will have a positive impact. On June 25th AARP announced a $60 million investment in the Dementia Defense Fund (DDF), an impact-driven venture capital fund that invests in innovative ideas related to dementia. With this donation, the DDF was able to…READ MORE

uMETHOD Launches Refreshed Branding and Website

uMETHOD, a healthcare technology company that makes precision medicine practical for physician practices, has launched a new website and updated its branding. The new brand which includes the tagline, Treatment Paths. Made Personal., reflects the company’s focus on using unique patient medical data and artificial intelligence to allow physicians to provide personalized care plans for their patients. The first offering from uMETHOD is the RestoreU METHOD for patients with memory…READ MORE

uMETHOD Health Announces Multiple Presentations at the 2018 AAIC

The Alzheimer’s Association International Conference (AAIC) is the largest international meeting dedicated to Alzheimer’s and dementia. It brings together researchers, physicians, and companies from all over the world to present and discuss the latest research and breakthroughs. uMETHOD Health will be attending AAIC for the third year in a row this July 22-26th. Our poster presentations this year include: Observations on the Frequency of Depression and Medications in an APOE…READ MORE

The Pink Ceiling Invests in uMETHOD

uMETHOD, a precision medicine company that uses artificial intelligence and unique patient medical information to address the multiple causes of chronic diseases, recently announced an investment from The Pink Ceiling.   The company’s initial solution, the RestoreU METHOD, targets Alzheimer’s Disease. “Two-thirds of people suffering from Alzheimer’s are women and two-thirds of the caregivers are women.” says uMETHOD co-founder and CEO Vik Chandra. “As the population ages, Alzheimer’s will become…READ MORE